BioNxt Solutions Inc. (CSE:BNXT)
Canada · Delayed Price · Currency is CAD 0.9500
+0.0100 (1.06%)
Aug 12, 2025, 3:54 PM EDT
Paramount Global Revenue
BioNxt Solutions had revenue of 22.85K CAD in the twelve months ending March 31, 2025, down -88.95% year-over-year. In the year 2024, BioNxt Solutions had annual revenue of 26.99K, down -92.75%.
Revenue (ttm)
22.85K
Revenue Growth
-88.95%
P/S Ratio
4,831.33
Revenue / Employee
n/a
Employees
n/a
Market Cap
110.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.99K | -345.26K | -92.75% |
| Dec 31, 2023 | 372.25K | 74.81K | 25.15% |
| Dec 31, 2022 | 297.44K | 10.94K | 3.82% |
| Dec 31, 2021 | 286.50K | -59.16K | -17.11% |
| Dec 31, 2020 | 345.65K | 137.54K | 66.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| Sienna Senior Living | 896.45M |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 177.69M |
| WELL Health Technologies | 990.34M |
| Extendicare | 1.51B |